Ukraine had the highest generic pharmaceutical market share among presented Eastern European and Central Asian countries, measuring at 98 percent in 2018. Tajikistan reported the lowest portion of generics at 60 percent.
Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Generics and biosimilars
Global overview
4
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Basic Statistic Global generic prescription drug revenues as share of prescribed revenue 2012-2026
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2023-2028
Top companies
4
U.S. market
6
- Premium Statistic Brand and generic prescription medication spending in the U.S. 2006-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic Unbranded generics revenue top corporations in U.S. 2017-2018
- Premium Statistic Unbranded generics market share top corporations in U.S. 2017-2018
- Premium Statistic Top pharma products by prescriptions U.S. 2021
Patent expiration
6
- Premium Statistic Projected sales at risk due to patent expiry 2014-2023
- Premium Statistic Top pharma companies by sales loss due to patent loss until 2018
- Premium Statistic Forecast of new brand and LOE impact in developed pharma markets 2019-2026
- Premium Statistic Top branded biologic drugs in the U.S. that will go generic by 2028
- Premium Statistic Time from brand drug launch to generic patent challenges U.S. 1995-2014
- Basic Statistic Comparison of pre-expiry and generic price for drugs U.S. 2015
Savings
7
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Total savings of top generic drugs in U.S. 2022
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2022
- Basic Statistic Savings through generic drug usage in the U.S., by age group 2022
- Basic Statistic Savings through generic drug usage in the U.S., by payer 2022
- Basic Statistic Percentage savings through generic drug usage in the U.S. by payer 2022
- Basic Statistic Savings through generic drug usage in the U.S., by age group share 2022
Biosimilars
7
- Premium Statistic Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
- Premium Statistic Country-wise biosimilar pipelines number in development worldwide 2017
- Premium Statistic Reduction in U.S. direct spending on originator biologics as of 2018
- Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2018
- Premium Statistic Share of insuline glargine sales Lantus vs. biosimilar US 2015-2017
- Premium Statistic Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- Basic Statistic Physician office payment for biosimilars in Medicare Part B 2022
Further related statistics
10
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Pfizer's ad spending 2006-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- U.S. branded prescription revenue forecast 2009-2015
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
Further Content: You might find this interesting as well
Statistics
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Pfizer's ad spending 2006-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- U.S. branded prescription revenue forecast 2009-2015
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
WHO. (September 2, 2020). Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country* [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/
WHO. "Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country*." Chart. September 2, 2020. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/
WHO. (2020). Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country*. Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/
WHO. "Share of Generic Medicines in The Pharmaceutical Market Volume in Eastern Europe and Central Asia in 2018, by Selected Country*." Statista, Statista Inc., 2 Sep 2020, https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/
WHO, Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country* Statista, https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/ (last visited June 10, 2024)
Share of generic medicines in the pharmaceutical market volume in Eastern Europe and Central Asia in 2018, by selected country* [Graph], WHO, September 2, 2020. [Online]. Available: https://www.statista.com/statistics/1169596/generic-medicine-market-share-eastern-europe-and-central-asia-by-country/